No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 3.8x · 10Y median 3.8x · 71st percentile · as of Oct 6, 2026
Annual revenue · last 1 fiscal years + TTM
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T15:07:23.905Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-10-06T15:07:23.905Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-10-06T15:07:23.905Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T15:07:23.905Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T15:07:23.905Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Ethos Technologies Inc. (LIFE) stock was $35.53 as of Oct 6, 2026, 11:05 AM EDT, down 1.67% from the previous close.
Ethos Technologies Inc. functions as a third-party administrator for insurance policies in various global markets, including the United States, India, and Singapore.
Insurance - Brokers · San Francisco, CA
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
Next Earnings Date
Nov 2, 2026
27 days away
EPS Estimate
0.37
Revenue Est.
$166.98M
Last Quarter Results
EPS
$0.53
vs Estimate
$0.28
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1LIFE | $2.25B | $35.53 | -1.67% | N/A | N/A | N/A | N/A |
| 2BHFAP | $2.26B | $13.64 | +0.26% | -4.94% | -5.42% | N/A | vs LIFE |
| 3BANR | $2.30B | $67.54 | +0.21% | +8.20% | +6.88% | +7.87% | vs LIFE |
| 4MBIN | $2.30B | $50.05 | +0.66% | +55.72% | +13.50% | N/A | vs LIFE |
| 5ETOR | $2.21B | $26.21 | +2.02% | -37.17% | N/A | N/A | vs LIFE |
| 6NWBI | $2.20B | $15.05 | +0.10% | +27.80% | +8.67% | +5.26% | vs LIFE |
forward FY estimate
N/A
$189.56M
vs Estimate
$117.32M
Consensus Rating
Based on 8 analysts
Average Price Target
$35.63
+0.3% upside
Low
$32.00
Current
$35.53
High
$40.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $0.10 | $0.11 | $0.11 | 3 |
| Quarter ending Dec 2026 | $0.13 | $0.14 | $0.16 | 3 |
| Quarter ending Mar 2027 | $0.32 | $0.33 | $0.36 | 1 |
| Quarter ending Jun 2027 | $0.27 | $0.28 | $0.30 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $-2.28 | $-2.08 | $-1.86 | 3 |
| FY 2027 | $0.90 | $1.06 | $1.22 | 3 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $157.64M | $166.98M | $178.86M | 5 |
| Quarter ending Dec 2026 | $180.92M | $185.96M | $195.32M | 5 |
| Quarter ending Mar 2027 | $243.47M | $248.54M | $263.52M | 4 |
| Quarter ending Jun 2027 | $240.16M | $245.16M | $259.93M | 4 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $721.64M | $735.62M | $757.38M | 6 |
| FY 2027 | $894.57M | $961.84M | $1.01B | 6 |
